NEWSFLASH: McKesson/HBOC drops three product linesMcKesson/HBOC’s Information Technology Business is dropping three product lines as part of a major restructuring effort designed to refocus the company on its core healthcare information
McKesson/HBOCs Information Technology Business is dropping three product lines as part of a major restructuring effort designed to refocus the company on its core healthcare information systems and information technologies business. The Alpharetta, GA-based company is discontinuing the Pathways Smart Medical Record for physician offices, Amisys Open managed-care system for payers, and PharmCare Windows-based pharmacy system. They are also suspending marketing efforts for the Paragon 2.9c HIS to address product performance issues.
McKesson/HBOC claims that these products have not met financial, quality, or customer satisfaction targets and that few customers will be affected by the product reorganization. The company intends to replace PharmCare with an updated product obtained through strategic alliance or acquisition and Pathways with the Web-based Abaton.com clinical EMR, which was recently obtained via acquisition. The firm also plans to enhance the Amisys 3000 product, including addressing HIPAA compliance.
Over the past 18 months, weve seen a slowdown in purchase decisions for these large, complex systems, said Glenn Rosenkoetter, president of ITBs Payer Solutions Group. We are revisiting our strategy for the high-end market and re-evaluating our delivery models.
Although all sales and marketing efforts for Paragon have been suspended, McKesson/HBOC plans to increase its investment in several other HIS products, including the Star 2000, Series 2000, and HealthQuest 2000, and to develop consulting services, an ASP service model, and an Internet-based environment for its current offerings. The company will likely seek strategic alliances for at least some of these new products, as indicated by its plans for the now-defunct PharmCare and Pathways.
© 2000 Miller Freeman, Inc., a United News & Media company.
MRI-Based AI Radiomics Model Offers 'Robust' Prediction of Perineural Invasion in Prostate Cancer
July 26th 2024A model that combines MRI-based deep learning radiomics and clinical factors demonstrated an 84.8 percent ROC AUC and a 92.6 percent precision-recall AUC for predicting perineural invasion in prostate cancer cases.
Breast MRI Study Examines Common Factors with False Negatives and False Positives
July 24th 2024The absence of ipsilateral breast hypervascularity is three times more likely to be associated with false-negative findings on breast MRI and non-mass enhancement lesions have a 4.5-fold likelihood of being linked to false-positive results, according to new research.
Can Polyenergetic Reconstruction Help Resolve Streak Artifacts in Photon Counting CT?
July 22nd 2024New research looking at photon-counting computed tomography (PCCT) demonstrated significantly reduced variation and tracheal air density attenuation with polyenergetic reconstruction in contrast to monoenergetic reconstruction on chest CT.